找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatocellular Carcinoma; Cellular and Molecul Rajagopal N. Aravalli,Clifford J. Steer Book 2014 The Author(s) 2014 Hepatocellular carcinom

[復(fù)制鏈接]
樓主: 召集會議
11#
發(fā)表于 2025-3-23 10:28:24 | 只看該作者
12#
發(fā)表于 2025-3-23 14:21:04 | 只看該作者
13#
發(fā)表于 2025-3-23 18:40:07 | 只看該作者
14#
發(fā)表于 2025-3-24 00:04:30 | 只看該作者
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action
15#
發(fā)表于 2025-3-24 04:17:44 | 只看該作者
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action
16#
發(fā)表于 2025-3-24 08:12:44 | 只看該作者
Rajagopal N. Aravalli,Clifford J. Steerontribute to the development and progression of prostate can.Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action
17#
發(fā)表于 2025-3-24 12:41:21 | 只看該作者
18#
發(fā)表于 2025-3-24 16:53:02 | 只看該作者
ion is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor. ...Historically, the gene expression program mediated by the AR has been poorly understood. However,
19#
發(fā)表于 2025-3-24 22:40:28 | 只看該作者
Hepatocellular Carcinoma978-3-319-09414-4Series ISSN 2194-1173 Series E-ISSN 2194-1181
20#
發(fā)表于 2025-3-25 01:07:21 | 只看該作者
Rajagopal N. Aravalli,Clifford J. SteerIncludes supplementary material:
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 05:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
横山县| 道孚县| 东平县| 东光县| 同心县| 会宁县| 宁阳县| 洛阳市| 丰顺县| 胶南市| 龙江县| 盐津县| 乐都县| 分宜县| 白城市| 嘉鱼县| 丰镇市| 昭觉县| 静海县| 临夏市| 如东县| 定安县| 大兴区| 上犹县| 凤山市| 额济纳旗| 龙里县| 顺义区| 望都县| 延吉市| 淅川县| 舒城县| 孟州市| 武冈市| 巫山县| 淳化县| 南涧| 翼城县| 宁安市| 玉山县| 秭归县|